Heterogeneity of thromboxane A2 (TP-) receptors: evidence from antagonist but not agonist potency measurements
Open Access
- 1 March 1991
- journal article
- Published by Wiley in British Journal of Pharmacology
- Vol. 102 (3) , 607-614
- https://doi.org/10.1111/j.1476-5381.1991.tb12220.x
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Evidence for homogeneity of thromboxane A2 receptor using structurally different antagonistsEuropean Journal of Pharmacology, 1988
- Synthesis of oxabicyclo[2.2.1]heptane prostanoids having thromboxane-like activity at sub-nanomolar concentrationsEuropean Journal of Medicinal Chemistry, 1988
- Interactions of Thromboxane A2 Analogs and Prostaglandins in Isolated Dog ArteriesJournal of Cardiovascular Pharmacology, 1987
- AH23848: a thromboxane receptor-blocking drug that can clarify the pathophysiologic role of thromboxane A2.Circulation, 1985
- Investigations on a selective non-prostanoic thromboxane antagonist, BM 13.177, in human plateletsThrombosis Research, 1984
- Synthesis of prostanoids with bicyclo[2.2.1]heptane, bicyclo[3.1.1]heptane and bicyclo[2.2.2]octane ring systems. Activities of 15-hydroxy epimers on human plateletsJournal of Medicinal Chemistry, 1982
- UK-37,248, A novel, selective thromboxane synthetase inhibitor with platelet anti-aggregatory and anti-thrombotic activityThrombosis Research, 1981
- Synthesis of prostaglandin H2Journal of the American Chemical Society, 1979
- How should values of pA2 and affinity constants for pharmacological competitive antagonists be estimated?Journal of Pharmacy and Pharmacology, 1978
- Aggregation of Blood Platelets by Adenosine Diphosphate and its ReversalNature, 1962